WHY IT MATTERS: If Indiana S.B. 250 passes without amendment, patients in the state who use hemp-derived cannabinoid beverages for sleep, anxiety, or pain relief may lose legal access to these products entirely, forcing them to seek alternatives that may be less safe or less predictable in dosing. CLINICAL OVERVIEW: Indiana’s proposed S.B. 250 threatens to eliminate legal hemp-derived cannabinoid beverage sales in the state, which could displace patients and consumers who currently rely on these regulated products for symptom management.